STORY FROM: Drugs & Medical Devices

Ill. Appeals Court Refuses to Reinstate Lupron ‘Off Label’ Action Against Abbott Labs

CHICAGO — An Illinois appeals court has refused to reinstate a lawsuit against Abbott Laboratories Inc. involving its endometriosis drug Lupron, finding the plaintiff failed to present “newly discovered evidence” addressing the adequacy of the drug’s warnings.

In a March 30 opinion, the Illinois Court of Appeals, 1st District, explained that the plaintiff’s expert testimony does not undermine the trial court’s independent conclusion that the Lupron warning was adequate as a matter of law.

In 2012, Iwona Johnson sought treatment at a Chicago hospital for heavy menstrual bleeding. She was prescribed Lupron, which is FDA-approved to treat endometriosis. However, the ...

Associated Documents
Opinion



Registered User Login

Username

Password

True